Executive Director, Drug Safety Evaluation @ (November 2019 - July 2020)
Executive Director, Toxicology and Pathology @ (November 2016 - November 2019)
Senior Director - Toxicology and Clinical Pathology @ (June 2011 - October 2016)
Director, Mechanistic and Predictive Toxicology @ (November 2009 - May 2011)
Director, Mechanistic and Predictive Toxicology @ (April 2008 - November 2009)
Associate Director, Clinical Pathology and Immunotoxicology @ (July 2004 - April 2008)
Senior Clinical Pathologist @ (April 1999 - July 2004)
Nathaniel Collins Education
Ohio State University
Doctor Of Philosophy
1994-1999
Colorado State University
Doctor Of Veterinary Medicine (Medicine)
1990-1994
Colorado State University
Bachelor Of Science (Microbiology)
1986-1990
Broomfield High School
Nathaniel Collins Summary
Nathaniel Collins, based in Bridgewater, NJ, US, is currently a Vice President, Nonclinical Safety Portfolio Leadership at Bristol-Myers Squibb. Nathaniel Collins brings experience from previous roles at Bristol-Myers Squibb, Celgene and Merck. Nathaniel Collins holds a 1994 - 1999 Doctor Of Philosophy @ Ohio State University. Nathaniel Collins has 1 emails on RocketReach.
Looking for a different Nathaniel Collins?
Find contact details for 700 million professionals.